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Pleural empyema is a frequent complication of
bacterial pneumonia in childhood but is rare in
neonates. Although adequate antibiotic concen-
trations in pleural fluid are usually obtained 
during systemic antibiotic therapy,1 patients with
multiloculation, late organization or poor response
to conservative treatment require more aggressive
procedures such as video-assisted thoracoscopic
surgery (VATS), intrapleural fibrinolytic agent in-
stallation and surgical decortication. Here, we de-
scribe a case of staphylococcal pneumonia in an
infant complicated with multiloculated empyema.
The patient was successfully treated with VATS
after failure of conventional intravenous antibi-
otics and chest tube drainage.
Case Report
gA 1-month and 13-day-old male infant, weighin
4630 g, was admitted to our emergency depart-
ment due to mild fever and coughing for 3 days.
He was born at term by normal delivery at an-
other hospital with a birth weight of 3480 g and
good Apgar scores. The maternal history was un-
remarkable and there was no prolonged rupture
of membranes. The infant had received one dose
of BCG and two doses of hepatitis B vaccine.
On admission, he was tachypneic with a res-
piratory rate of 68/minute and bilateral sub-
costal retractions. In 40% head-box oxygen, the
oxygen saturation was 96%. The right chest was
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dull to percussion and air entry to the right lung
was poor. His temperature was 38.5°C. No other
abnormal physical signs were noted. Chest X-ray
showed total white-out of the right chest and
slight displacement of the mediastinal structures
to the left (Figure 1). Computed tomography 
revealed multiloculated fluid collections and
collapsed lung lobes over the right chest. 
The peripheral leukocyte count was 12,100/μL
(neutrophils 79.2%, lymphocytes 9.3%, mono-
cytes 10.8%, eosinophils 0.4%), hemoglobin
concentration was 9.7 g/dL, platelet count was
447,000/μL and C-reactive protein level was 
elevated to 21.3 mg/dL. Arterial blood gas analy-
sis showed pH 7.319, PaCO2 51 mmHg, PO2
89.2 mmHg, bicarbonate 25.6 mmol/L and base
excess −0.5. Blood biochemistry revealed sodium
138 mmol/L, potassium 5.8 mmol/L, blood urea
nitrogen 8 mg/dL, creatinine 0.5 mg/dL, glucose
120 mg/dL, alanine aminotransferase 16 IU/L, and
aspartate aminotransferase 13 IU/L. Diagnostic as-
piration of the right pleural cavity yielded 4 mL
of purulent fluid (red blood cells 1008/μL, white
blood cells 360/μL, pH 7.2, protein 4900 mg/dL,
lactate dehydrogenase 2285 IU/L), which showed
a pure growth of methicillin-sensitive Staphylococcus
aureus 3 days later. For better drainage, the patient
was intubated and a 12-F chest tube was inserted
into the fifth intercostal space of the right chest,
which yielded another 30 mL of fibrin enriched
fluid. Cultures of blood, spinal fluid and urine
were all sterile. Mycobacterial culture of the 
pleural fluid was also negative.
Pleural drainage after admission was associ-
ated with a decline in the respiratory rate and
oxygen requirement. Parenteral antibiotic treat-
ment was started with ampicillin (100 mg/kg/
day) and gentamicin (5 mg/kg/day), and then
switched to oxacillin (150 mg/kg/day) when
methicillin-sensitive S. aureus was isolated from
the pleural aspirate. Fever also subsided ythe da
after drainage, but tachypnea around 50/minute
persisted. On the 5th day of hospitalization, no
more fluid was drained from the chest tube. His
respiratory rate remained unchanged and bilateral
subcostal retraction became more prominent.
Multiloculated effusions with collapsed lung lobes
could be seen on right chest sonogram (Figure 2).
After the family’s consent was obtained, pleural
decortication was performed with VATS. Exami-
nation with a 3 mm thoracoscope (0°; Olympus
Corp., Tokyo, Japan) found little effusion, but sub-
stantial fibrin and pleural thickening were iden-
tified and removed. The patient’s condition
improved rapidly and the antibiotic treatment was
continued for 3 weeks. He was discharged 26 days
after admission. Follow-up at 2 weeks, 1 month,
t6 months and 1 year after discharge found tha  
the was asymptomatic and thriving. Chest X-ray a
1 month was free of any lesion.
Discussion
Pneumonia is not an uncommon disease in pe-
diatric medicine. Although its etiology is viral in
iF gure 1. h h l h f h hC est X-ray s ows tota  w ite-out o  t e rig t
chest.
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iF gure 2. Sonogram shows multiloculated empyema with
collapsed lung lobes (arrow).
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most cases, bacterial pneumonia can be lethal and
cause severe complications in developing coun-
tries. Among the complications of bacterial pneu-
monia, pleural empyema, which is defined as pus
collection between the lungs and chest wall, has
increased in incidence in recent decades.2–4 It oc-
curs in 5–10% of children with bacterial pneumo-
nia.5 Empyema is suggested when pleural fluid
shows a white cell count >10,000/mm3, glucose 
< 50 mg/dL or less than half the serum level,
high protein, high lactate dehydrogenase, and
pH less than 7.2.5 Pathogens encountered in
pleural empyema in children include S. aureus,
Streptococcus pneumoniae, Haemophilus influenzae
and anaerobes. With the introduction of pneu-
mococcal conjugate vaccine for infants beginning
at 2 months of age in the Western world, the inci-
dence of empyema caused by S. pneumoniae has
decreased significantly. Staphylococcal empyema
has become more frequent instead.4
In the neonatal period, Group B Streptococcus is
the most frequent cause of bacterial pneumonia
acquired at delivery. Pathogens causing bacterial
pneumonia after birth are commonly acquired in
the nursery or at home and include S. aureus,
Gram-negative enteric bacilli and Chlamydia tra-
chomatis. Staphylococcal pneumonia in infants is
almost always associated with empyema.6 The
bacteria descend to the alveoli, form microab-
scesses, rupture and result in empyema. Among
the toxins produced by S. aureus, Panton-
Valentine leukocidin (PVL) has been suggested
to play an important role in the formation of
rapidly progressive necrotizing pneumonia mainly
in healthy children and young adults.7 By induc-
ing pronounced release of histamine, enzymes
and chemotactic components, severe tissue necro-
sis results and the pneumonia caused by PVL-
positive S. aureus becomes a more severe disease
entity with a poor prognosis.
Most pediatric empyemas result from compli-
cations of bacterial pneumonia. The disease
process has been classified into three stages:
stage 1, exudative stage; stage 2, fibrinopurulent
stage; stage 3, organizing stage.8,9 Various modal-
ities from intravenous antibiotics, chest tube
drainage, video-assisted thoracostomy to surgical
decortication have been suggested for the treat-
yment of different disease stages. Ultrasonograph
yis sensitive in characterizing the fluid densit
and detecting the presence of fronds, septations
and loculations.10 However, the optimal man-
 agement of progressive empyema in children
remains controversial.11 In recent studies, intra-
pleural streptokinase has been advocated to 
enhance pleural drainage, especially in multi-
loculated empyema in children. However, there
cis no short-term clinical benefit in pediatri
rempyema, and this therapy may be reserved fo
preventing pleural thickening in the long-
term.11,12 Moreover, the timing and dosage of in-
trapleural fibrinolytic therapy in children are still
equivocal, especially in the neonatal group. This
is why VATS was selected for the treatment of this
patient instead of intrapleural fibrinolytic ther-
yapy. Kalfa et al suggested that early thoracoscop
(< 4 days after diagnosis) is greatly beneficial to
children with empyema by shortening disease
progression.13 Previous studies focused only on
pleural empyema in children, however, and the
treatment of empyema in neonates or young in-
fants still largely consists of intravenous antibi-
otics and catheter drainage.
yThe optimal duration of antimicrobial therap
for neonatal pleural empyema remains unclear.
Courses of at least 3–4 weeks are recommended
for staphylococcal and mixed bacterial empyemas.
tFurthermore, pleural fluid culture is an importan
diagnostic tool leading to identification of the bac-
terial pathogen in 60–80% of cases, in contrast to
blood culture, which is positive in 13–31%.14,15
yAlthough our patient was free of symptoms shortl
after the procedure, intravenous antibiotics were
continued for 3 weeks. In previous reports in chil-
dren, the mean length of stay was 6.2–8.2 days
shorter in patients who underwent early VATS
compared to those who underwent tube thoracos-
tomy,14,16,17 rand it is thus sensible that a shorte
duration of antimicrobial therapy can be used in
neonates who have undergone VATS.
Recent studies have found strong evidence
suggesting that early thoracoscopic decortication
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can shorten the length of admission and results
in more rapid recovery in addition to intra-
venous antibiotics.9,15,18 Our patient received
VATS after it became clear that chest tube drain-
age was inadequate. Clinical improvement after
the procedure was significant and quick resolu-
tion of pleural thickening was found on chest 
X-ray within 2 months, which is at the low end
of the 2–16-month period of resolution reported
by Satish et al.17 However, whether better resolu-
tion of pleural thickening can ameliorate pul-
monary function or prevent restrictive lung
diseases requires further investigation.
The present case is the youngest reported pa-
tient to receive VATS. A previous study by Liu
et al of thoracoscopic-assisted management of
postpneumonic empyema in children refractory
to medical response included a 2-month-old pa-
tient which they described as the youngest re-
ported patient to receive this treatment.19 The
present case suggests that very young age, includ-
ing neonatal age, is not a contraindication for
VATS treatment of pleural empyema. While intra-
venous antibiotics and catheter drainage remain
the mainstays of treatment of neonatal empyema,
this case suggests that adjunctive therapy such as
VATS could be beneficial for more satisfactory
outcomes.
It is difficult to perform endoscopic surgery in
infants because of the limited pleural space. A
traditional 10 mm or even 5 mm thoracoscope is
not feasible for use in infants and especially in
neonates because the intercostal space is too nar-
row for insertion of the scope. In this patient,
a 3 mm miniscope was used. The visual field of 
a 3 mm miniscope, however, is so narrow that a
higher skill level is required for instrument ma-
nipulation. Owing to the fact that there is no inde-
pendent ventilation for infants, the tidal volume
has to be decreased to provide more space for tho-
racoscopy, and in this case, a few seconds of “no
ventilation” were needed during the operation.
This increases the risk of the operation. Compared
with the similar operation in adults, VATS in 
infants requires more experience, patience and 
cooperation with the anesthesiologist.
rIn conclusion, this case illustrates that afte
the failure of chest tube drainage and intra-
venous antibiotics, treatment of pleural empyema
gwith VATS can be successful in infants as youn
as 1-month-old. Early thoracoscopic decortica-
tion and intrapleural fibrinolytic agents have
been suggested to shorten hospitalization and
promote earlier recovery in children. However,
rthe outcome of pleural empyema in neonates o
fyoung infants still depends on the adequacy o
antimicrobial treatment and tube thoracostomy.
 This case suggests that VATS can be a safe and
r effective treatment for neonates, but furthe
studies are needed.
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